Two‐year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double‐blind, placebo‐controlled …

JD Adachi, KG Saag, PD Delmas… - … : Official Journal of …, 2001 - Wiley Online Library
Objective To evaluate the continued efficacy and safety of alendronate (ALN) for up to 2
years in patients receiving glucocorticoids. Methods This is a 12‐month extension of a …
被引用次数：722 相关文章

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled …

JD Adachi, KG Saag, PD Delmas… - Arthritis and …, 2001 - europepmc.org
Objective To evaluate the continued efficacy and safety of alendronate (ALN) for up to 2
years in patients receiving glucocorticoids. Methods This is a 12-month extension of a …

[引用][C] Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo …

JD Adachi, KG Saag, PD Delmas… - Arthritis and …, 2001 - produccioncientifica.ucm.es

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled …

JD Adachi, KG Saag, PD Delmas… - Arthritis and …, 2001 - scholars.northwestern.edu
Objective. To evaluate the continued efficacy and safety of alendronate (ALN) for up to 2
years in patients receiving glucocorticoids. Methods. This is a 12-month extension of a …

[引用][C] Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids. A randomized, double-blind, placebo …

JD ADACHI, KG SAAG… - Arthritis and …, 2001 - pascal-francis.inist.fr
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients
receiving glucocorticoids. A randomized, double-blind, placebo-controlled extension trial …

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled …

JD Adachi, KG Saag, PD Delmas… - Arthritis and …, 2001 - pubmed.ncbi.nlm.nih.gov
Objective To evaluate the continued efficacy and safety of alendronate (ALN) for up to 2
years in patients receiving glucocorticoids. Methods This is a 12-month extension of a …

[引用][C] Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo …

JD Adachi, KG Saag, PD Delmas, UA Liberman… - Arthritis & …, 2001 - cir.nii.ac.jp
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients
receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial | CiNii …

Two‐year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double‐blind, placebo‐controlled …

JD Adachi, KG Saag, PD Delmas… - … : Official Journal of …, 2001 - Wiley Online Library
Objective To evaluate the continued efficacy and safety of alendronate (ALN) for up to 2
years in patients receiving glucocorticoids. Methods This is a 12‐month extension of a …

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids-A randomized, double-blind, placebo-controlled …

JD ADACHI, KG SAAG, PD DELMAS… - ARTHRITIS AND …, 2001 - biblio.ugent.be
Author JD ADACHI, KG SAAG, PD DELMAS, UA LIBERMAN, RD EMKEY, E SEEMAN, NE
LANE, Jean Kaufman (UGent), PEE POUBELLE, F HAWKINS, R CORREA-ROTTER, CJ …

[引用][C] Tow-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo …

A JD - Arthritis Rheum, 2001 - cir.nii.ac.jp
Tow-year effects of alendronate on bone mineral density and vertebral fracture in patients
receiving glucocorticoids : a randomized, double-blind, placebo-controlled extension trial …